Abstract
Twenty-six patients with asthma were treated with Syoseiryuto for three months or longer. In 66.7% of the cases, it was determined to be useful.
In order to be useful for the treatment of asthma, using more than 0.15mg/kg of body weight of Syoseiryuto is recommended. Cases appropriate for Syoseiryuto were considered to have an atopic history with high serum IgE levels and a tendency toward nasal trouble. On the other hand, those for Saibokuto were considered to have a tendency toward infection-induced asthma, hyperactivity, sweating and fatigue, and abdominal pain and cold. The importance of selection of cases for the indication of these drugs is suggested. It is suggested also that proper selection of cases for these drugs will render them more effective.
